SFXN4 and cerebrovascular disorder: Among the seven prioritized candidate genes, KO mouse models provided compelling evidence of functional roles for HSD17B12, ERAP2, and SFXN4. Specifically, deletion of HSD17B12 was associated with disruptions in fatty acid metabolism, directly linking lipid metabolism dysregulation to cerebrovascular disease pathology.